Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ACTRN12626000583347) titled 'Schizophrenia Platform for Improving Recovery with Integrated Trials (SPIRIT) - Master Protocol' on May 11.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Assignment: Other
Type of endpoint: Efficacy
Primary Sponsor: University of Queensland
Condition:
Schizophrenia
Schizophrenia
Mental Health - Schizophrenia
Intervention:
The four domains of SPIRIT are:
1. Cardiometabolic (e.g. subcutaneous Tirzepatide)
2. Lifestyle and social functioning domain (e.g. exercise interventions)
3. Psychosis domain (e.g. augmentation agents for psychosis)
Recruitment Status: No...